Stromanormalised vessel density predicts benefit from adjuvant fluorouracilbased chemotherapy in patients with stage IIIII colon cancer

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer

05:10 EDT 10 Jul 2019 | Nature Publishing

More From BioPortfolio on "Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer"